NASDAQ:CLPT

Clearpoint Neuro Stock Insider Trading

Healthcare > Medical - Devices

Buy CLPT

*Your capital is at risk

$14.94

+0.360 (+2.47%)

At Close: Jul 31, 2026

ClearPoint Neuro Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -37.67. In total, the insiders bought 1.39M and sold 291.32K CLPT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-37.67
● Buy	1.39M shares
● Sell	291.32K shares
77% Buy Activity Negligible or No Correlation
Sell Signal Medium Confidence Jun 17, 2026 Analysis Breakdown: Supported by a negative Insider Power Score of -37.67. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 12, 2026 Sell	Common Stock F-InKind	Stigall L. Jeremy Chief Business Officer	Officer	15 151 Value: $174.7K
Mar 12, 2026 Buy	Restricted Stock Units M-Exempt	Stigall L. Jeremy Chief Business Officer	Officer	30 995 Value: $357.4K
Mar 12, 2026 Buy	Common Stock M-Exempt	Sabra Mazin Chief Operating Officer	C-Suite Officer	26 101 Value: $300.9K
Mar 12, 2026 Sell	Common Stock F-InKind	Sabra Mazin Chief Operating Officer	C-Suite Officer	13 281 Value: $153.1K
Mar 12, 2026 Buy	Restricted Stock Units M-Exempt	Sabra Mazin Chief Operating Officer	C-Suite Officer	26 101 Value: $300.9K
Mar 11, 2026 Buy	Restricted Stock Units M-Exempt	Stigall L. Jeremy Chief Business Officer	Officer	8 291 Value: $96.3K
Mar 11, 2026 Sell	Common Stock F-InKind	Stigall L. Jeremy Chief Business Officer	Officer	3 224 Value: $37.5K
Mar 11, 2026 Buy	Common Stock M-Exempt	D'alessandro Danilo Chief Financial Officer	C-Suite Officer	4 145 Value: $48.2K
Mar 11, 2026 Sell	Common Stock F-InKind	D'alessandro Danilo Chief Financial Officer	C-Suite Officer	2 109 Value: $24.5K
Mar 11, 2026 Buy	Restricted Stock Units M-Exempt	D'alessandro Danilo Chief Financial Officer	C-Suite Officer	4 145 Value: $48.2K
Mar 11, 2026 Buy	Common Stock M-Exempt	Stigall L. Jeremy Chief Business Officer	Officer	8 291 Value: $96.3K
Mar 06, 2026 Buy	Common Stock M-Exempt	Stigall L. Jeremy Chief Business Officer	Officer	17 778 Value: $177.8K
Mar 06, 2026 Sell	Common Stock F-InKind	Stigall L. Jeremy Chief Business Officer	Officer	6 913 Value: $69.1K
Mar 06, 2026 Buy	Restricted Stock Units M-Exempt	Stigall L. Jeremy Chief Business Officer	Officer	17 778 Value: $177.8K
Mar 06, 2026 Buy	Common Stock M-Exempt	Sabra Mazin Chief Operating Officer	C-Suite Officer	13 827 Value: $138.3K
Mar 06, 2026 Sell	Common Stock F-InKind	Sabra Mazin Chief Operating Officer	C-Suite Officer	7 036 Value: $70.4K
Mar 06, 2026 Buy	Restricted Stock Units M-Exempt	Sabra Mazin Chief Operating Officer	C-Suite Officer	13 827 Value: $138.3K
Mar 06, 2026 Buy	Common Stock M-Exempt	D'alessandro Danilo Chief Financial Officer	C-Suite Officer	18 765 Value: $187.7K
Mar 06, 2026 Sell	Common Stock F-InKind	D'alessandro Danilo Chief Financial Officer	C-Suite Officer	9 548 Value: $95.5K
Mar 06, 2026 Buy	Restricted Stock Units M-Exempt	D'alessandro Danilo Chief Financial Officer	C-Suite Officer	18 765 Value: $187.7K
Mar 03, 2026 Sell	Common Stock F-InKind	Sabra Mazin Chief Operating Officer	C-Suite Officer	3 380 Value: $29.9K
Mar 03, 2026 Buy	Common Stock M-Exempt	Sabra Mazin Chief Operating Officer	C-Suite Officer	6 642 Value: $58.7K
Mar 03, 2026 Buy	Restricted Stock Units M-Exempt	Stigall L. Jeremy Chief Business Officer	Officer	8 856 Value: $78.2K
Mar 03, 2026 Sell	Common Stock F-InKind	Stigall L. Jeremy Chief Business Officer	Officer	4 506 Value: $39.8K
Mar 03, 2026 Buy	Common Stock M-Exempt	Stigall L. Jeremy Chief Business Officer	Officer	8 856 Value: $78.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CLEARPOINT NEURO, INC.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into...

Read Full Profile Here